NEW YORK (GenomeWeb News) – BioReference Laboratories, an Elmwood Park, NJ-based clinical lab firm, today reported that its fiscal third quarter revenues increased 16 percent year over year and cited strong growth for its GeneDx subsidiary.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.